The Claim
Variants in the SLC2A9 gene are associated with altered risk of gout in European populations, including those from the UK, Croatia, and Germany.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with certain versions of the SLC2A9 gene have a different likelihood of developing gout compared to those without these versions, and this pattern is observed in European populations from the UK, Croatia, and Germany.
See the scientific wording
The association between SLC2A9 variants and gout risk is replicated across multiple European populations, including UK, Croatian, and German cohorts, suggesting this genetic effect is consistent across these groups.
Proteins in the kidney that move uric acid from the blood into urine are less effective when certain gene versions are present, causing more uric acid to stay in the blood. Higher blood uric acid levels lead to crystal formation in joints, which triggers gout.
What the research says
1 studyScientists found that people with certain versions of the SLC2A9 gene are more likely to get gout, and this was true in three different European countries — the UK, Croatia, and Germany. This means the gene link to gout isn’t just a fluke in one group; it’s a real and consistent pattern.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.